IBDEI0EE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6564,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,6565,0)
 ;;=196.0^^31^412^100
 ;;^UTILITY(U,$J,358.3,6565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6565,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,6565,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,6565,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,6566,0)
 ;;=196.1^^31^412^101
 ;;^UTILITY(U,$J,358.3,6566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6566,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,6566,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,6566,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,6567,0)
 ;;=196.8^^31^412^102
 ;;^UTILITY(U,$J,358.3,6567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6567,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,6567,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,6567,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,6568,0)
 ;;=V10.51^^31^412^55
 ;;^UTILITY(U,$J,358.3,6568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6568,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,6568,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,6568,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,6569,0)
 ;;=V10.3^^31^412^56
 ;;^UTILITY(U,$J,358.3,6569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6569,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,6569,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,6569,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,6570,0)
 ;;=V10.41^^31^412^57
 ;;^UTILITY(U,$J,358.3,6570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6570,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,6570,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,6570,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,6571,0)
 ;;=V10.05^^31^412^58
 ;;^UTILITY(U,$J,358.3,6571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6571,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,6571,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,6571,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,6572,0)
 ;;=V10.03^^31^412^59
 ;;^UTILITY(U,$J,358.3,6572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6572,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,6572,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,6572,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,6573,0)
 ;;=V10.60^^31^412^61
 ;;^UTILITY(U,$J,358.3,6573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6573,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,6573,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,6573,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,6574,0)
 ;;=V10.11^^31^412^62
 ;;^UTILITY(U,$J,358.3,6574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6574,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,6574,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,6574,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,6575,0)
 ;;=V10.79^^31^412^63
 ;;^UTILITY(U,$J,358.3,6575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6575,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,6575,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,6575,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,6576,0)
 ;;=V10.82^^31^412^64
 ;;^UTILITY(U,$J,358.3,6576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6576,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,6576,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,6576,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,6577,0)
 ;;=V10.02^^31^412^65
 ;;^UTILITY(U,$J,358.3,6577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6577,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,6577,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,6577,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,6578,0)
 ;;=V10.43^^31^412^66
 ;;^UTILITY(U,$J,358.3,6578,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0EE
